Effects of the COVID-19 Pandemic on Pediatric Hospitalizations for Life-Threatening Conditions

Cassandra L Louis1, Parthak Prodhan2, Daniel B Horton3

  • 1Division of Pediatric Critical Care, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.

Insights

The COVID-19 pandemic

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Virology

Background:

  • Mitigation measures during the COVID-19 pandemic reduced non-SARS-CoV-2 virus circulation.
  • This created a unique research window into viral-triggered pediatric conditions.

Purpose of the Study:

  • To analyze the impact of reduced viral circulation on pediatric hospitalizations for specific conditions.
  • To quantify changes in hospital admission rates for acute flaccid paralysis, myocarditis, and Guillain-Barré syndrome.

Main Methods:

  • Retrospective analysis of pediatric hospitalization data.
  • Comparison of admission rates before and during pandemic mitigation periods.
  • Focus on conditions with known viral triggers.

Main Results:

  • A significant decrease in first pediatric hospitalizations for acute flaccid paralysis (-96.2%).
  • Substantial reductions observed in myocarditis (-79.4%) and Guillain-Barré syndrome (-44.1%) admissions.
  • Overall decline in other viral-associated pediatric conditions.

Conclusions:

  • Reduced circulation of common viruses significantly lowered pediatric hospitalizations for several neurological and cardiac conditions.
  • The findings highlight the critical role of viral infections in pediatric morbidity.
  • Pandemic-related public health interventions demonstrated a measurable impact on non-COVID-19 pediatric health outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
255
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K